PRGO
Perrigo Company PLC
NYSE: PRGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.66
+0.52% today
Updated 2026-09-11
Market cap
$1.98B
P/E ratio
—
P/S ratio
0.48x
EPS (TTM)
$-12.09
Dividend yield
7.96%
52W range
$9 – $21
Volume
2.8M
Perrigo Company PLC (PRGO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.66
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$57.12
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $4.1B | $4.5B | $4.7B | $4.4B | $4.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -41.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.